Steven Andrews
Research Subjects
Research Interests
Steven Andrews has a total of 69 co-authors. Here are the top co-authors by number of shared publications:
- Aditya Shrawat
College of Natural Sciences, The University of Texas at Austin, Austin, Texas
27 shared publications - Akshay Bhat
Livestrong Cancer Institutes, Department of Oncology, Dell Medical School, The University of Texas at Austin, Austin, Texas
27 shared publications - Alessia Lodi
Department of Nutritional Sciences, College of Natural Sciences and Department of Pediatrics, Dell Medical School, The University of Texas at Austin, Austin, TX, USA
27 shared publications - Ashok Singh
Dell Medical School, The University of Texas at Austin, Austin, Texas
27 shared publications - Dan Qi
Department of Neurosurgery and Neuroscience Institute, Baylor Scott & White Health, Temple, TX 76508, USA
27 shared publications - Daniel J. McGrail
Center for Immunotherapy and Precision Immuno-Oncology, Cleveland Clinic, Cleveland, OH, USA; Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA
27 shared publications
Latest Publications
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Data from Landscape of MicroRNA Regulatory Network Architecture and Functional Rerouting in Cancer
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from Landscape of MicroRNA Regulatory Network Architecture and Functional Rerouting in Cancer
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Data from Landscape of MicroRNA Regulatory Network Architecture and Functional Rerouting in Cancer
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from Landscape of MicroRNA Regulatory Network Architecture and Functional Rerouting in Cancer
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Data from Landscape of MicroRNA Regulatory Network Architecture and Functional Rerouting in Cancer
Supplementary Figures and Supplementary Table S1
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from Landscape of MicroRNA Regulatory Network Architecture and Functional Rerouting in Cancer
Supplementary Figures and Supplementary Table S1
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Data from Landscape of MicroRNA Regulatory Network Architecture and Functional Rerouting in Cancer
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from Landscape of MicroRNA Regulatory Network Architecture and Functional Rerouting in Cancer
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Data from Landscape of MicroRNA Regulatory Network Architecture and Functional Rerouting in Cancer
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from Landscape of MicroRNA Regulatory Network Architecture and Functional Rerouting in Cancer
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Data from Landscape of MicroRNA Regulatory Network Architecture and Functional Rerouting in Cancer
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from Landscape of MicroRNA Regulatory Network Architecture and Functional Rerouting in Cancer
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Data from Landscape of MicroRNA Regulatory Network Architecture and Functional Rerouting in Cancer
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from Landscape of MicroRNA Regulatory Network Architecture and Functional Rerouting in Cancer
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Data from Landscape of MicroRNA Regulatory Network Architecture and Functional Rerouting in Cancer
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from Landscape of MicroRNA Regulatory Network Architecture and Functional Rerouting in Cancer
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Data from Landscape of MicroRNA Regulatory Network Architecture and Functional Rerouting in Cancer
Somatic mutations are a major source of cancer development, and many driver mutations have been identified in protein coding regions. However, the function of mutations located in miRNA and their target binding sites throughout the human genome remains largely unknown. Here, we built detailed cancer-specific miRNA regulatory networks across 30 cancer types to systematically analyze the effect of mutations in miRNAs and their target sites in 3′ untranslated region (3′ UTR), coding sequence (CDS), and 5′ UTR regions. A total of 3,518,261 mutations from 9,819 samples were mapped to miRNA–gene interactions (mGI). Mutations in miRNAs showed a mutually exclusive pattern with mutations in their target genes in almost all cancer types. A linear regression method identified 148 candidate driver mutations that can significantly perturb miRNA regulatory networks. Driver mutations in 3′UTRs played their roles by altering RNA binding energy and the expression of target genes. Finally, mutated driver gene targets in 3′ UTRs were significantly downregulated in cancer and functioned as tumor suppressors during cancer progression, suggesting potential miRNA candidates with significant clinical implications. A user-friendly, open-access web portal (mGI-map) was developed to facilitate further use of this data resource. Together, these results will facilitate novel noncoding biomarker identification and therapeutic drug design targeting the miRNA regulatory networks.Significance:A detailed miRNA–gene interaction map reveals extensive miRNA-mediated gene regulatory networks with mutation-induced perturbations across multiple cancers, serving as a resource for noncoding biomarker discovery and drug development.
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessData from Landscape of MicroRNA Regulatory Network Architecture and Functional Rerouting in Cancer
Somatic mutations are a major source of cancer development, and many driver mutations have been identified in protein coding regions. However, the function of mutations located in miRNA and their target binding sites throughout the human genome remains largely unknown. Here, we built detailed cancer-specific miRNA regulatory networks across 30 cancer types to systematically analyze the effect of mutations in miRNAs and their target sites in 3′ untranslated region (3′ UTR), coding sequence (CDS), and 5′ UTR regions. A total of 3,518,261 mutations from 9,819 samples were mapped to miRNA–gene interactions (mGI). Mutations in miRNAs showed a mutually exclusive pattern with mutations in their target genes in almost all cancer types. A linear regression method identified 148 candidate driver mutations that can significantly perturb miRNA regulatory networks. Driver mutations in 3′UTRs played their roles by altering RNA binding energy and the expression of target genes. Finally, mutated driver gene targets in 3′ UTRs were significantly downregulated in cancer and functioned as tumor suppressors during cancer progression, suggesting potential miRNA candidates with significant clinical implications. A user-friendly, open-access web portal (mGI-map) was developed to facilitate further use of this data resource. Together, these results will facilitate novel noncoding biomarker identification and therapeutic drug design targeting the miRNA regulatory networks.Significance:A detailed miRNA–gene interaction map reveals extensive miRNA-mediated gene regulatory networks with mutation-induced perturbations across multiple cancers, serving as a resource for noncoding biomarker discovery and drug development.
- 26 May 2025
- Published by Elsevier in Journal of Nutrition Education and Behavior
- Vol. 57 (7) , 614-626
Pilot Trial of Nutri, a Digital Intervention for Personalized Dietary Management of Diabetes in Safety-Net Primary Care
- 26 May 2025
- Published by Elsevier in Journal of Nutrition Education and Behavior
- Vol. 57 (7) , 614-626
Pilot Trial of Nutri, a Digital Intervention for Personalized Dietary Management of Diabetes in Safety-Net Primary Care